Avg closing price
Price range

10 Ken Griffin Beam Therapeutics Trades

Ken Griffin acquired 94.3 Thousand Beam Therapeutics shares worth $2.87 Million. That's 0.00% of their equity portfolio (2307th largest holding). The first Beam Therapeutics trade was made in Q1 2020. Since then Ken Griffin bought shares four more times and sold shares on five occasions. The investor's estimated purchase price is $8.38 Million, resulting in a loss of 66%.

Avg closing price
Price range
Increased shares by 76.9% (+41 Thousand shares) Q3 2022
Avg closing price $57.05
Price range $39.79 - $70.31
Sold 67.6% shares (-111 Thousand shares) Q2 2022
Avg closing price $39.75
Price range $29.86 - $62.36
Increased shares by 103.8% (+83.8 Thousand shares) Q1 2022
Avg closing price $65.59
Price range $53.73 - $82.16
Sold 62.7% shares (-135 Thousand shares) Q4 2021
Avg closing price $85.62
Price range $68.02 - $99.06
Increased shares by 900.3% (+195 Thousand shares) Q3 2021
Avg closing price $100.46
Price range $84.37 - $133.60
Sold 86.3% shares (-136 Thousand shares) Q2 2021
Avg closing price $79.68
Price range $64.12 - $128.71
New holding (+157 Thousand shares) Q1 2021
Avg closing price $95.13
Price range $71.28 - $120.75
Sold -27.1 Thousand shares Q3 2020
Avg closing price $24.81
Price range $19.00 - $30.57
Sold 68.6% shares (-59.2 Thousand shares) Q2 2020
Avg closing price $21.55
Price range $15.26 - $28.66
New holding (+86.3 Thousand shares) Q1 2020
Avg closing price $21.73
Price range $13.31 - $29.20

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!